Suppr超能文献

如何诊治重症监护病房患者的病毒感染。

How to approach and treat viral infections in ICU patients.

作者信息

Kelesidis Theodoros, Mastoris Ioannis, Metsini Aliki, Tsiodras Sotirios

机构信息

4th Department of Internal Medicine, Attikon University Hospital, National and Kapodistrian University of Athens School of Medicine, 1 Rimini Street, GR-12462 Haidari, Athens, Greece.

出版信息

BMC Infect Dis. 2014 Nov 28;14:321. doi: 10.1186/1471-2334-14-321.

Abstract

Patients with severe viral infections are often hospitalized in intensive care units (ICUs) and recent studies underline the frequency of viral detection in ICU patients. Viral infections in the ICU often involve the respiratory or the central nervous system and can cause significant morbidity and mortality especially in immunocompromised patients. The mainstay of therapy of viral infections is supportive care and antiviral therapy when available. Increased understanding of the molecular mechanisms of viral infection has provided great potential for the discovery of new antiviral agents that target viral proteins or host proteins that regulate immunity and are involved in the viral life cycle. These novel treatments need to be further validated in animal and human randomized controlled studies.

摘要

患有严重病毒感染的患者通常在重症监护病房(ICU)住院,最近的研究强调了在ICU患者中检测到病毒的频率。ICU中的病毒感染通常累及呼吸道或中枢神经系统,尤其在免疫功能低下的患者中可导致显著的发病率和死亡率。病毒感染治疗的主要方法是支持治疗以及在有可用药物时进行抗病毒治疗。对病毒感染分子机制的深入了解为发现新的抗病毒药物提供了巨大潜力,这些药物靶向病毒蛋白或调节免疫并参与病毒生命周期的宿主蛋白。这些新型治疗方法需要在动物和人类随机对照研究中进一步验证。

相似文献

4
Current progress in antiviral strategies.抗病毒策略的当前进展。
Trends Pharmacol Sci. 2014 Feb;35(2):86-102. doi: 10.1016/j.tips.2013.11.006. Epub 2014 Jan 14.
5
[Antiviral therapy: from influenza to Pfeiffer's disease].[抗病毒治疗:从流感到 Pfeiffer 病]
Internist (Berl). 2006 Dec;47(12):1245-50. doi: 10.1007/s00108-006-1721-9.

引用本文的文献

1
Non-COVID-19 respiratory viral infection.非新冠病毒呼吸道病毒感染
Breathe (Sheff). 2022 Mar;18(1):210151. doi: 10.1183/20734735.0151-2021. Epub 2022 May 10.
2
Characteristics of viral pneumonia in the COVID-19 era: an update.新冠疫情时代病毒性肺炎的特征:最新进展
Infection. 2021 Aug;49(4):607-616. doi: 10.1007/s15010-021-01603-y. Epub 2021 Mar 29.
3
Update in Viral Infections in the Intensive Care Unit.重症监护病房病毒感染的最新情况
Front Med (Lausanne). 2021 Feb 23;8:575580. doi: 10.3389/fmed.2021.575580. eCollection 2021.
6
COVID-19 revisiting inflammatory pathways of arthritis.COVID-19 再次审视关节炎的炎症通路。
Nat Rev Rheumatol. 2020 Aug;16(8):465-470. doi: 10.1038/s41584-020-0451-z. Epub 2020 Jun 19.
7
Baricitinib for COVID-19: a suitable treatment?巴瑞替尼用于治疗新冠肺炎:一种合适的治疗方法?
Lancet Infect Dis. 2020 Sep;20(9):1012-1013. doi: 10.1016/S1473-3099(20)30262-0. Epub 2020 Apr 3.
8
New advances in CNS immunity against viral infection.中枢神经系统对病毒感染的免疫新进展。
Curr Opin Virol. 2018 Feb;28:116-126. doi: 10.1016/j.coviro.2017.12.003. Epub 2017 Dec 29.

本文引用的文献

1
RNAi and miRNA in viral infections and cancers.RNA干扰和微小RNA在病毒感染与癌症中的作用
Asian Pac J Cancer Prev. 2013;14(12):7045-56. doi: 10.7314/apjcp.2013.14.12.7045.
3
Corticosteroids for viral myocarditis.用于病毒性心肌炎的皮质类固醇。
Cochrane Database Syst Rev. 2013 Oct 18;2013(10):CD004471. doi: 10.1002/14651858.CD004471.pub3.
4
The antiviral activities of ISG15.ISG15的抗病毒活性。
J Mol Biol. 2013 Dec 13;425(24):4995-5008. doi: 10.1016/j.jmb.2013.09.041. Epub 2013 Oct 3.
5
Influenza and endemic viral pneumonia.流感和地方性病毒性肺炎。
Crit Care Clin. 2013 Oct;29(4):1069-86. doi: 10.1016/j.ccc.2013.06.003.
6
Favipiravir (T-705), a novel viral RNA polymerase inhibitor.法匹拉韦(T-705),一种新型的病毒 RNA 聚合酶抑制剂。
Antiviral Res. 2013 Nov;100(2):446-54. doi: 10.1016/j.antiviral.2013.09.015. Epub 2013 Sep 29.
9
Herbal medicines for viral myocarditis.用于治疗病毒性心肌炎的草药
Cochrane Database Syst Rev. 2013 Aug 28(8):CD003711. doi: 10.1002/14651858.CD003711.pub5.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验